| Poster
No. |
Presenter |
Title |
P-01 |
Kouki Matsuda
[Kumamoto Univ.] |
Inhibition of HIV-1 entry by a tricyclic coumarin
GUT-70 |
|
P-02
O-35-3B |
Ryusho Kariya
[Kumamoto Univ.] |
HAMLET and BAMLET induces cell death of Primary Effusion
Lymphoma |
P-03 |
Hiroki Goto
[Kumamoto Univ.] |
Targeting IL-6 in the crosstalk between HIV-1 infection
and primary effusion lymphoma |
P-04 |
Eriko Kudo
[Kumamoto Univ.] |
HIV-1 restriction factor, Murr1 (COMMD1), suppresses
Toll-like receptor signaling in HIV-1 latently infected cells |
P-05 |
Farzana Bhuyan
[Kumamoto Univ.] |
Features of HIV-1 replication in fibrocytes, the
recently identified target cells of HIV-1 |
P-06
O-18-3A |
Md Abu Osman
[Kumamoto Univ.] |
M-CSF diminishes anti-HIV-1 activity of cytokines
including IL-32 |
P-07 |
Hesham E. Nasser
[Kumamoto Univ.] |
Phenotypes of fibrocytes, the recently identified
HIV-1 host cells |
P-08 |
Michihiro Hashimoto
[Kumamoto Univ.] |
The selective activation of anti-inflammatory M2-type
macrophages by HIV-1 Nef is mediated by a serine/threonine kinase
TAK1 |
P-09 |
Kodai Kawano
[Kumamoto Univ.] |
HIV-1 suppresses LINE-1 retrotransposition |
P-10
O-33-3B |
Kazuhiko Maeda
[Kumamoto Univ.] |
Role of mammalian TREX-2 component GANP in HIV-1
infection |
P-11 |
Kazuaki Monde
[Kumamoto Univ.] |
HERV-K Gag coassembles with HIV-1 Gag via its CA
domain and changes morphology of HIV-1 particles to reduce the infectivity |
P-12 |
Yusuke Nakano
[Kumamoto Univ.] |
Preferential recognition of monomeric forms of CCR5
by HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1 |
P-13 |
Hiromi Terasawa
[Kumamoto Univ.] |
Competitive resistance of a CXCR4-using HIV-1 lacking
amino acid substitutions in the V3 loop of gp120 to a CXCR4 inhibitor
AMD3100 |
P-14 |
Junko S Takeuchi
[Kyoto Univ.] |
Quantification of HIV cell-free and cell-to-cell
transmissions based on experimental-mathematical investigations |
P-15
O-19-3A |
Kristel Paola Ramirez Valdez
[Kumamoto Univ.] |
Can antibodies contribute to controlling infection
with transmitted/founder virus? |
P-16 |
Kazuki Tanaka
[Kumamoto Univ.] |
Miniaturization of antibodies against CD4-induced
epitope on gp120 |
P-17 |
Yasuhiro Maruta
[Kumamoto Univ.] |
Post-attachment neutralization as a mechanism of
efficient activities of scFv from anti-V3 monoclonal antibody |
P-18
O-34-3B |
Muntasir Alam
[Kumamoto Univ.] |
Effects of Enfuvirtide resistant mutations on the
sensitivity to neutralizing antibodies |
P-19
O-28-3B |
Shohei Taketomi
[Tokyo Medical and Dental Univ.] |
Structure activity relationship studies on a spacer
moiety of small molecular CXCR4 antagonists as potent HIV-1 entry
inhibitors |
P-20 |
Yuki Hirota
[Tokyo Medical and Dental Univ.] |
Indole-type small CD4 mimic molecules targeting an
HIV envelope protein gp120 |
P-21 |
Shigeyoshi Harada
[NIID] |
In vitro selection of bifunctional CD4 mimic small
compounds (NBD analogues) using bulk and cloned primary isolates |
P-22 |
Samatchaya Boonchawalit
[Kumamoto Univ.] |
Analysis of relationships between Maraviroc (MVC)
resistant mutations and sensitivity to antibody-mediated neutralization |
P-23
O-29-3B |
Masayuki Amano
[Kumamoto Univ.] |
Discovery of small compounds which induce HIV-1 Capsid
protein degradation |
P-24 |
Tomofumi Nakamura
[Kumamoto Univ.] |
Dynamics of IN multimerization and a potent modulation
by allosteric HIV-1 integrase (IN) inhibitors in living cells using
bimolecular fluorescence complementation (BiFC) |
P-25 |
Joseph R. Campbell
[Kumamoto Univ.] |
Accessing HIV-1 Integrase LEDGF Binding Inhibitors
using bimolecular fluorescence complementation (BiFC) |
P-26 |
Hiromi Ogata-Aoki
[Kumamoto Univ.] |
Prophylactic administration of Raltegravir alters
dynamics of HIVmC dissemination in huPBMC-transplanted NOJ mice |
P-27
O-31-3B |
Amber R. Moore
[Kumamoto Univ.] |
Evaluation of HIV-1 reverse transcriptase (RT) heterodimerization
within living cells using bimolecular fluorescence complementation
(BiFC) |
P-28
O-30-3B |
Hironori Hayashi
[Kumamoto Univ.] |
The dimerization inhibition mechanism of darunavir
and the dynamics of HIV-1 protease dimerization |
P-29
O-32-3B |
Pedro Miguel Salcedo Gomez
[Kumamoto Univ.] |
GRL-04810 and GRL-05010; novel difluoride-containing
HIV-1 protease inhibitors (PIs) with potent antiviral activity and
favorable penetration across the blood-brain barrier |
P-30 |
Manabu Aoki
[Kumamoto Health Science Univ.] |
Novel HIV-1 protease inhibitors, GRL-015, GRL-085,
and GRL-097, potently inhibit the replication of multi-PI-resistant
HIV-1s |
P-31
O-27-3A |
Takayuki Chikata
[Kumamoto Univ.] |
Host-specific adaptation of HIV-1 subtype B in the
Japanese population |
P-32
O-22-3A |
Xiaoming Sun
[Kumamoto Univ.] |
Presentation of two HLA-A*24:02-restricted overlapping
epitopes elicit different patterns of CD8 T cell repertoire and select
same escape mutation in HIV-infected patients |
P-33
O-21-3A |
Nozomi Kuse
[Kumamoto Univ.] |
Control of HIV-1 by Pol283-8-specific CTLs in HLA-B*51:01+long-term
non progressors |
P-34 |
Tomohiro Akahoshi
[Kumamoto Univ.] |
Reversion of a CTL escape mutation by escape mutant-specific
CTLs |
P-35 |
Zhansong Lin
[Kumamoto Univ.] |
Inhibition of human NK cell function by an HLA-Cw*12:02-restricted
HIV-1 CTL epitope peptide and its escape mutant peptide |
P-36 |
Tran Van Giang
[Kumamoto Univ.] |
Establishment of a cohort of treatment-naive patients
chronically infected with HIV-1 in Hanoi |
P-37
O-25-3A |
Keiko Sakai
[Kumamoto Univ.] |
The lack of a significant impact of HIV-1 Gag replication
capacities on patients’ disease outcomes in a chronically infected,
treatment-naive Japanese cohort |
P-38 |
Mohammad Arif Rahman
[Kumamoto Univ.] |
Effect of protease inhibitor- and integrase inhibitor-resistant
mutations on HIV-1-specific CTL recognition |
P-39
O-24-3A |
Macdonald Mahiti
[Kumamoto Univ.] |
Differential modulation of Nef-mediated downregulation
activity of HLA class I alleles in HIV-1 chronic infection |
P-40
O-26-3A |
Stanley C. Meribe
[Kumamoto Univ.] |
Acceleration of disease Progression by a single naturally-arising
polymorphism, within functional region of HIV-1 nef |
P-41 |
Doreen Kamori
[Kumamoto Univ.] |
HLA-A*02 allelic variants differently influence amino
acid polymorphisms in an immunodominant epitope of HIV-1 Vpr |
P-42 |
Mako Toyoda
[Kumamoto Univ.] |
Analysis of naturally-occurring polymorphisms of
HIV-1 Nef that impair CD4 down-regulation activity |
P-43
O-20-3A |
Chihiro Motozono
[Kinki Univ.] |
Molecular basis of a dominant T cell response to
an HIV reverse transcriptase epitope presented by the protective allele
HLA-B*51:01 |
P-44 |
Hiroshi Ishii
[NIID] |
Distinctive phenotype profiles of Env-specific CD8+
T cells in the chronic phase of SIV infection |
P-45
O-23-3A |
Koji Watanabe
[NCGM] |
Cross-clade CD8+ T cell responses in chronically
HIV-1 clade A/E-infected individuals |
P-46 |
Manthana Mitchai
[Kumamoto Univ.] |
HIV infection associated thrombocytopenia : a favourable
clinical outcome in HAART therapy patient |
P-47
O-36-3B |
Junko Tanuma
[NCGM] |
Stably low prevalence of drug resistant HIV transmission
while antiretroviral therapy was scaling up in Southern Vietnam: 2008-2012 |
P-48
O-37-3B |
Kazuhiro Matsuoka
[Nagoya Medical Center] |
Cross-Resistance Mutation Patterns in Non-Nucleoside
Reverse Transcriptase Inhibitors Rilpivirine and Etravirine in Clinical
Isolates |
P-49 |
Mayumi Imahashi
[Nagoya Medical Center] |
Dissociation between insertion/deletion polymorphisms
of the APOBEC3B gene and HIV-1 risk: a population-based matched-cohort
study in Japan |
P-50 |
Takeshi Nishijima
[NCGM/ Kumamoto Univ.] |
Incidence and risk factors for incident hepatitis
C infection among men who have sex with men with HIV-1 infection in
a large urban HIV clinic in Tokyo |
P-51 |
Masahiro Ishikane
[NCGM] |
Acute C hepatitis in Japanese HIV-infected patients
in this decade |
P-52 |
Daisuke Mizushima
[NCGM/ Kumamoto Univ.] |
Clinical utility of quantitative cytomegalovirus
DNA and its kinetics for predicting cytomegalovirus end-organ disease
in HIV-infected patients |
P-53 |
Fumihide Kanaya
[NCGM] |
Monitoring of bone side effects during maraviroc
containing treatment |
P-54 |
Masaaki Toyama
[Kagoshima Univ.] |
A tetrahydrotetramethylbenzophenanthridinone derivative
selectively inhibits the proliferation of adult T-cell leukemia (ATL)
cell lines in vitro |
P-55 |
Yohann White
[University of the West Indies, Jamaica] |
Impact of co-infection with human immunodeficiency
virus type-1 and human T-cell lymphotropic virus type-1 on the latent
HIV-1 reservoir in Jamaican patients with dual infection |
